Brain MRI atrophy quantification in MS: From methods to clinical application.
Patients with the main clinical phenotypes of multiple sclerosis (MS) manifest varying degrees of brain atrophy beyond that of normal aging. Assessment of atrophy helps to distinguish clinically and cognitively deteriorating patients and predicts those who will have a less-favorable clinical outcome...
Автори: | Rocca, M, Battaglini, M, Benedict, R, De Stefano, N, Geurts, J, Henry, R, Horsfield, M, Jenkinson, M, Pagani, E, Filippi, M |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
American Academy of Neurology
2016
|
Схожі ресурси
Схожі ресурси
-
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI
за авторством: Houshang Amiri, та інші
Опубліковано: (2018-01-01) -
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
за авторством: Vrenken, H, та інші
Опубліковано: (2013) -
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis
за авторством: Vrenken, H, та інші
Опубліковано: (2013) -
Relaxometry and brain myelin quantification with synthetic MRI in MS subtypes and their associations with spinal cord atrophy
за авторством: Theodoros Ladopoulos, та інші
Опубліковано: (2022-01-01) -
Measurement of whole-brain and gray matter atrophy in multiple sclerosis: assessment with MR imaging
за авторством: Storelli, L, та інші
Опубліковано: (2018)